Montreal, June 17, 2019 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian

MONTREAL, May 28, 2019 I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce the signing of a

MONTREAL, April 10, 2019 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce the

MONTREAL, April 1, 2019 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, proudly announces its 30-year anniversary

MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of

MONTREAL, November 1st, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the

I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market. MONTREAL, October 17, 2018 (GLOBE NEWSWIRE) – I-MED

I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands MONTREAL, October 2, 2018 (GLOBE NEWSWIRE) – I-MED

West Island businesses get financial boost from Quebec Government The Quebec government is giving several West Island companies a financial boost. A total of $443,103